×

What are you searching for?




Healthcare

4 Min read

CSL Continues to Advance R&D Capabilities

Published On 09 Dec 2019 10:57 AM


SHARE THIS ARTICLE  


SYDNEY, Australia – CSL Limited (ASX:CSL; USOTC:CSLLY) is gradually improving its Research & Development (R&D) pipeline and capabilities to deliver a greater range of products that will meet the standards of patients’ needs, according to Head of Research & Development Dr. William Mezzanotte.

Dr. Mezzanotte pointed out that the company is building on its role in plasma therapy by identifying promising new medic....


Tags : R&D Capabilities, CSL Continues, Advance R&D, unique treatment , ,
SHARE THIS ARTICLE  

Leave a comment 

comments (0)